Legis Daily

Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act

USA118th CongressHR-6094| House 
| Updated: 12/17/2024
Doris O. Matsui

Doris O. Matsui

Democratic Representative

California

Cosponsors (26)
Mikie Sherrill (Democratic)David J. Trone (Democratic)Neal P. Dunn (Republican)Mariannette Miller-Meeks (Republican)Melanie A. Stansbury (Democratic)Steve Cohen (Democratic)Paul Tonko (Democratic)Donald G. Davis (Democratic)Shri Thanedar (Democratic)Jake Auchincloss (Democratic)Gus M. Bilirakis (Republican)Sheila Cherfilus-McCormick (Democratic)Don Bacon (Republican)Mike Kelly (Republican)Richard Hudson (Republican)Dean Phillips (Democratic)Eleanor Holmes Norton (Democratic)August Pfluger (Republican)Salud O. Carbajal (Democratic)Joe Neguse (Democratic)Mike Quigley (Democratic)Brian K. Fitzpatrick (Republican)Lori Trahan (Democratic)Mike Thompson (Democratic)Lizzie Fletcher (Democratic)Josh Gottheimer (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act or the PROTECT Rare Act This bill provides for coverage under the Medicare prescription drug benefit, Medicaid, and private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals). Such drugs must be supported by peer-reviewed research or medical experts and must not have been reviewed unfavorably in specified compendia or used in a way that conflicts with approved labels.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 26, 2023
Introduced in House
Oct 26, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Nov 3, 2023
Referred to the Subcommittee on Health.
Dec 17, 2024
Referred to the Subcommittee on Health.
  • October 26, 2023
    Introduced in House


  • October 26, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • November 3, 2023
    Referred to the Subcommittee on Health.


  • December 17, 2024
    Referred to the Subcommittee on Health.

Health

Health care costs and insuranceHealth care coverage and accessMedicaidMedicarePrescription drugs

Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act

USA118th CongressHR-6094| House 
| Updated: 12/17/2024
Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act or the PROTECT Rare Act This bill provides for coverage under the Medicare prescription drug benefit, Medicaid, and private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals). Such drugs must be supported by peer-reviewed research or medical experts and must not have been reviewed unfavorably in specified compendia or used in a way that conflicts with approved labels.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 26, 2023
Introduced in House
Oct 26, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Nov 3, 2023
Referred to the Subcommittee on Health.
Dec 17, 2024
Referred to the Subcommittee on Health.
  • October 26, 2023
    Introduced in House


  • October 26, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • November 3, 2023
    Referred to the Subcommittee on Health.


  • December 17, 2024
    Referred to the Subcommittee on Health.
Doris O. Matsui

Doris O. Matsui

Democratic Representative

California

Cosponsors (26)
Mikie Sherrill (Democratic)David J. Trone (Democratic)Neal P. Dunn (Republican)Mariannette Miller-Meeks (Republican)Melanie A. Stansbury (Democratic)Steve Cohen (Democratic)Paul Tonko (Democratic)Donald G. Davis (Democratic)Shri Thanedar (Democratic)Jake Auchincloss (Democratic)Gus M. Bilirakis (Republican)Sheila Cherfilus-McCormick (Democratic)Don Bacon (Republican)Mike Kelly (Republican)Richard Hudson (Republican)Dean Phillips (Democratic)Eleanor Holmes Norton (Democratic)August Pfluger (Republican)Salud O. Carbajal (Democratic)Joe Neguse (Democratic)Mike Quigley (Democratic)Brian K. Fitzpatrick (Republican)Lori Trahan (Democratic)Mike Thompson (Democratic)Lizzie Fletcher (Democratic)Josh Gottheimer (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Health care costs and insuranceHealth care coverage and accessMedicaidMedicarePrescription drugs